Voriconazole Inhalation Powder

DRUG3 trials

Sponsors

TFF Pharmaceuticals, Inc.

Conditions

Allergic Bronchopulmonary AspergillosisAnastomotic InfectionAspergillus TracheobronchitisAsthmaChronic Pulmonary AspergillosisHealthyInvasive Pulmonary AspergillosisPulmonary Fungal Infection

Phase 1

Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma

CompletedNCT04576325

TFF Pharmaceuticals, Inc.Asthma

Start: 2020-11-15End: 2021-11-12Updated: 2021-11-18

Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects

CompletedNCT04872231

TFF Pharmaceuticals, Inc.Healthy

Start: 2019-11-22End: 2020-08-26Updated: 2021-05-06

Unknown Phase

Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis

TFF Pharmaceuticals, Inc.Allergic Bronchopulmonary Aspergillosis, Anastomotic Infection, Aspergillus Tracheobronchitis +3

Updated: 2024-11-21